Adverse event totals15

The totals the trial posted for each group.

1 to 15 of 15

Total	Group	Affected	At risk
Total, all-cause mortality	Placebo	0	26
Total, all-cause mortality	Ranolazine 750 mg	0	26
Total, all-cause mortality	Dronedarone 225 mg	0	26
Total, all-cause mortality	Ranolazine 750 mg + Dronedarone 225 mg	0	27
Total, all-cause mortality	Ranolazine 750 mg + Dronedarone 150 mg	0	26
Total, other adverse events	Placebo	9	26
Total, other adverse events	Ranolazine 750 mg	15	26
Total, other adverse events	Dronedarone 225 mg	14	26
Total, other adverse events	Ranolazine 750 mg + Dronedarone 225 mg	12	27
Total, other adverse events	Ranolazine 750 mg + Dronedarone 150 mg	14	26
Total, serious adverse events	Placebo	1	26
Total, serious adverse events	Ranolazine 750 mg	7	26
Total, serious adverse events	Dronedarone 225 mg	2	26
Total, serious adverse events	Ranolazine 750 mg + Dronedarone 225 mg	5	27
Total, serious adverse events	Ranolazine 750 mg + Dronedarone 150 mg	1	26

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01522651/event-totals